ImpediMed Limited
ASX: IPD.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Erik Anderson
- Employees
- 83
- Headquarters
- Pinkenba, Australia
- IPO year
- 2007
- Market cap
- A$15.3M
- Website
- https://www.impedimed.com
Loading IPD…
Loading profile data…Frequently asked questions about IPD
What does ImpediMed Limited (IPD.AX) do?
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7,...
Where does IPD.AX trade?
ImpediMed Limited (IPD.AX) trades on the Australian Securities Exchange.
What sector is IPD.AX in?
ImpediMed Limited (IPD.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of ImpediMed Limited?
Erik Anderson is the chief executive officer of ImpediMed Limited (IPD.AX).
Where is ImpediMed Limited headquartered?
ImpediMed Limited is headquartered in Australia.
Does IPD.AX pay a dividend?
ImpediMed Limited (IPD.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IPD.AX go public?
ImpediMed Limited (IPD.AX) completed its initial public offering in 2007.